Roberto Zarrabeitia

2.6k total citations
29 papers, 751 citations indexed

About

Roberto Zarrabeitia is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Roberto Zarrabeitia has authored 29 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 23 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Roberto Zarrabeitia's work include Vascular Anomalies and Treatments (27 papers), Tracheal and airway disorders (23 papers) and Sharing Economy and Platforms (7 papers). Roberto Zarrabeitia is often cited by papers focused on Vascular Anomalies and Treatments (27 papers), Tracheal and airway disorders (23 papers) and Sharing Economy and Platforms (7 papers). Roberto Zarrabeitia collaborates with scholars based in Spain, Switzerland and Italy. Roberto Zarrabeitia's co-authors include Luisa M. Botella, Carmelo Bernabéu, Virginia Albiñana, Francisco Sanz‐Rodríguez, Africa Fernández-L, Lucía Recio-Poveda, Carmelo Morales‐Angulo, Julia Nguyen, Robert P. Hebbel and José Antonio Parra and has published in prestigious journals such as Clinical Chemistry, European Respiratory Journal and Cardiovascular Research.

In The Last Decade

Roberto Zarrabeitia

29 papers receiving 742 citations

Peers

Roberto Zarrabeitia
Cornelis J.J. Westermann Netherlands
Fatima S Govani United Kingdom
Arthur A. Glatfelter United States
Freya Droege Germany
Frances Hines United Kingdom
Nuria Almendro Spain
Fleur S van Dijk Netherlands
Jung‐Il Lee South Korea
Isabelle Quintin‐Roué France
Peter Pernicone United States
Cornelis J.J. Westermann Netherlands
Roberto Zarrabeitia
Citations per year, relative to Roberto Zarrabeitia Roberto Zarrabeitia (= 1×) peers Cornelis J.J. Westermann

Countries citing papers authored by Roberto Zarrabeitia

Since Specialization
Citations

This map shows the geographic impact of Roberto Zarrabeitia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Zarrabeitia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Zarrabeitia more than expected).

Fields of papers citing papers by Roberto Zarrabeitia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Zarrabeitia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Zarrabeitia. The network helps show where Roberto Zarrabeitia may publish in the future.

Co-authorship network of co-authors of Roberto Zarrabeitia

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Zarrabeitia. A scholar is included among the top collaborators of Roberto Zarrabeitia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Zarrabeitia. Roberto Zarrabeitia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buscarini, Elisabetta, Luisa M. Botella, Urban W. Geisthoff, et al.. (2019). Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. Orphanet Journal of Rare Diseases. 14(1). 28–28. 75 indexed citations
2.
Martín–Llahí, Marta, Agustı́n Albillos, Rafael Bañares, et al.. (2017). Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver. Gastroenterología y Hepatología (English Edition). 40(8). 538–580. 15 indexed citations
3.
Zarrabeitia, Roberto, Concepción Fariñas-Álvarez, Miguel Santibáñez, et al.. (2017). Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT). Health and Quality of Life Outcomes. 15(1). 19–19. 40 indexed citations
4.
Martín–Llahí, Marta, Agustı́n Albillos, Rafael Bañares, et al.. (2017). Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología. 40(8). 538–580. 14 indexed citations
5.
Parra, José Antonio, Roberto Zarrabeitia, Concepción Fariñas-Álvarez, et al.. (2016). Screening pulmonary arteriovenous malformations in a large cohort of Spanish patients with hemorrhagic hereditary telangiectasia. International Journal of Cardiology. 218. 240–245. 7 indexed citations
6.
Diago, Carlos Antonio Amado, et al.. (2013). Prevalence of hereditary hemorrhagic telangiectasia (HHT) and genotype–phenotype correlation in Spain. European Journal of Internal Medicine. 24. e183–e184. 1 indexed citations
7.
Tabruyn, Sébastien P., Sylvain Hansen, Luisa Ojeda‐Fernández, et al.. (2013). MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells. Angiogenesis. 16(4). 877–887. 27 indexed citations
8.
Fontalba, Ana, José L. Fernández-Luna, Roberto Zarrabeitia, et al.. (2013). Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1. BMC Medical Genetics. 14(1). 121–121. 6 indexed citations
9.
Albiñana, Virginia, Lucía Recio-Poveda, Roberto Zarrabeitia, Carmelo Bernabéu, & Luisa M. Botella. (2012). Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia. Thrombosis and Haemostasis. 108(7). 41–53. 45 indexed citations
10.
11.
Zarrabeitia, Roberto, et al.. (2010). A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT). Current Vascular Pharmacology. 8(4). 473–481. 31 indexed citations
12.
Montés, Ana Fernández, et al.. (2010). Enfermedad de Rendu-Osler con afectación hepática: primer trasplante en España. Medicina Clínica. 135(12). 552–555. 4 indexed citations
13.
Albiñana, Virginia, et al.. (2010). Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Thrombosis and Haemostasis. 103(3). 441–451. 67 indexed citations
14.
Sánchez, José Hernán Parra, Jesús Zarauza, Concepción Fariñas-Álvarez, et al.. (2009). Graded contrast echocardiography in pulmonary arteriovenous malformations. European Respiratory Journal. 35(6). 1279–1285. 43 indexed citations
15.
Fontalba, Ana, Africa Fernández-L, Virginia Albiñana, et al.. (2008). Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia. BMC Medical Genetics. 9(1). 75–75. 30 indexed citations
16.
Fernández-L, Africa, Eva M. Garrido‐Martín, Francisco Sanz‐Rodríguez, et al.. (2007). Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): Regulation of ALK-1/endoglin pathway in endothelial cells. Thrombosis and Haemostasis. 97(2). 254–262. 49 indexed citations
17.
Fernández-L, Africa, Francisco Sanz‐Rodríguez, Roberto Zarrabeitia, et al.. (2006). Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1. Human Mutation. 27(3). 295–295. 44 indexed citations
18.
Zarrabeitia, Roberto, et al.. (2005). Telangiectasia hemorrágica hereditaria. Medicina Clínica. 124(15). 583–587. 13 indexed citations
19.
Fernández-L, Africa, Francisco Sanz‐Rodríguez, Roberto Zarrabeitia, et al.. (2005). Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovascular Research. 68(2). 235–248. 87 indexed citations
20.
Zarrabeitia, Roberto, et al.. (1999). Paludismo importado en Cantabria. Enfermedades Infecciosas y Microbiología Clínica. 17(9). 476. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelis J.J. Westermann Breakdown of academic impact, for papers by Fatima S Govani Breakdown of academic impact, for papers by Arthur A. Glatfelter Breakdown of academic impact, for papers by Freya Droege Breakdown of academic impact, for papers by Frances Hines Breakdown of academic impact, for papers by Nuria Almendro Breakdown of academic impact, for papers by Fleur S van Dijk Breakdown of academic impact, for papers by Jung‐Il Lee Breakdown of academic impact, for papers by Isabelle Quintin‐Roué Breakdown of academic impact, for papers by Peter Pernicone
Rankless by CCL
2026